Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Silvec Biologics Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 examiner and 1 art unit, so the reported activity is concentrated in one technical and examination setting.
VIJAYARAGHAVAN, JAGAMYA NMN is the busiest examiner, with 1 pending matter. The available data presents no examiner or art-unit distribution to coordinate. Counsel can focus on a complete response to the identified record, with particular attention to claim construction and the examination approach associated with this assignment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 61.9% | +51.4% |
| POPA, ILEANA | 1 | 21.7% | +15.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18858201 | RNA VECTORS WITH HAIRPIN-LIKE INSERTS | VIJAYARAGHAVAN, JAGAMYA NMN | — |
| 18311552 | RNA Vectors with Hairpin-like Inserts | POPA, ILEANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18858201 | RNA VECTORS WITH HAIRPIN-LIKE INSERTS | VIJAYARAGHAVAN, JAGAMYA NMN | — |
| 18311552 | RNA Vectors with Hairpin-like Inserts | POPA, ILEANA | — |
| Art Unit | Apps |
|---|---|
| 1633 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18858201 | RNA VECTORS WITH HAIRPIN-LIKE INSERTS | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103§112Other | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18311552 | RNA Vectors with Hairpin-like Inserts | POPA, ILEANA | 1633 | §102§103§112Other | Non-Final OA | — | Pending | May 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSilvec Biologics Inc. has 2 pending office actions as of November 2026, spread across 1 art units and 2 examiners.
Jagamya Nmn Vijayaraghavan has the most, with 1 of Silvec Biologics Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.